Quick Answer
Chemours Co reported Revenue (ASC 606) of $5.81 billion for fiscal year 2025.
Chemours Co Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $5.81B | +0.4% |
| 2024 | $5.78B | -4.9% |
| 2023 | $6.08B | -11.0% |
| 2022 | $6.83B | +7.7% |
| 2021 | $6.34B | +27.7% |
| 2020 | $4.97B | -10.1% |
| 2019 | $5.53B | -16.8% |
| 2018 | $6.64B | +7.4% |
| 2017 | $6.18B | +14.5% |
| 2016 | $5.40B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.50B | -0.9% | -7.4% |
| June 30, 2025 | $1.61B | +3.9% | +18.1% |
| March 31, 2025 | $1.37B | +0.4% | -9.3% |
| September 30, 2024 | $1.51B | +1.4% | -3.0% |
| June 30, 2024 | $1.55B | -5.4% | +14.1% |
| March 31, 2024 | $1.36B | -11.3% | -8.4% |
| September 30, 2023 | $1.49B | -16.3% | -9.5% |
| June 30, 2023 | $1.64B | -14.2% | +7.0% |
- Chemours Co showed an increase of +0.4% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, Chemours Co’s revenue (asc 606) has grown by 7.6% (from $5.40 billion to $5.81 billion).
- The most recent figure is from Chemours Co’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: